Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for anti-embolism stockings. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global anti-embolism stockings market from 2025 to 2032.

Key Insights:

•Anti-Embolism Stockings Market Size (2025E): USD 783.6 Million
•Projected Market Value (2032F): USD 1,117.4 Million
•Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Anti-Embolism Stockings Market - Report Scope:

Anti-embolism stockings are medical-grade compression hosiery designed to prevent deep vein thrombosis (DVT) and other venous thromboembolic events in patients who are immobile or undergoing surgery. These stockings apply graduated compression to improve blood circulation in the legs, reducing the risk of clot formation. The market caters to hospitals, surgical centers, rehabilitation facilities, and homecare users, offering various types of stockings including thigh-high, knee-high, and pantyhose styles made from materials such as nylon and spandex. Market growth is driven by increasing awareness of venous disorders, rising surgical procedures globally, and growing geriatric population requiring preventive care.

Market Growth Drivers:

The global anti-embolism stockings market is propelled by several key factors, including increasing prevalence of cardiovascular diseases and venous thromboembolism, which drive the demand for preventive healthcare products. The rising number of surgeries and hospitalizations, especially in aging populations, further fuel market expansion. Growing adoption of minimally invasive surgical techniques and enhanced recovery protocols that emphasize DVT prevention also contribute to market growth. Additionally, technological advancements in stocking materials and designs, improving comfort, durability, and efficacy, encourage greater patient compliance and broaden usage.

Market Restraints:

Despite promising growth prospects, the anti-embolism stockings market faces challenges related to patient non-compliance due to discomfort and difficulty in usage. Variability in reimbursement policies and limited awareness in emerging economies restrict market penetration. Moreover, competition from alternative DVT prevention methods, such as pharmacological treatments and pneumatic compression devices, poses a challenge. Addressing these barriers requires education initiatives, product innovation for enhanced comfort, and improved healthcare policy support.

Market Opportunities:

The anti-embolism stockings market presents significant growth opportunities driven by increasing healthcare infrastructure development and rising adoption of home healthcare services. Expanding applications beyond postoperative care, including use in long-haul travel and chronic venous insufficiency management, broaden market scope. Integration of smart textiles and wearable technology to monitor compression levels and patient adherence can revolutionize the market. Strategic collaborations, investment in R&D, and regional market expansion are essential to capitalize on emerging opportunities and sustain competitive advantage.

Key Questions Answered in the Report:

•What are the primary factors driving the growth of the anti-embolism stockings market globally?
•Which product types and end-user segments are driving anti-embolism stockings adoption across different healthcare settings?
•How are technological advancements reshaping the competitive landscape of the anti-embolism stockings market?
•Who are the key players contributing to the anti-embolism stockings market, and what strategies are they employing to maintain market relevance?
•What are the emerging trends and future prospects in the global anti-embolism stockings market?

Competitive Intelligence and Business Strategy:

These companies invest in R&D to develop advanced compression hosiery with improved material technologies and ergonomic designs, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, distributors, and regulatory bodies facilitate market access and promote adoption. Moreover, emphasis on clinical evidence, patient education, and comfort enhancement fosters market growth and improves patient outcomes in the evolving anti-embolism landscape.

Key Companies Profiled:

•Medtronic (Covidien)
•Sigvaris
•Medi
•BSN Medical
•Juzo
•3M
•Bauerfeind AG
•Thuasne Corporate
•Pretty Legs Hosiery
•Salzmann-Group
•Paul Hartmann
•Cizeta Medicali
•Belsana Medical
•Gloria Med
•Zhende Medical Group

Anti-Embolism Stockings Market Research Segmentation:

The anti-embolism stockings market encompasses a diverse range of products, materials, applications, and end-user segments, addressing various clinical needs and patient populations.

By Product:

•Calf-length
•Thigh-length

By Demography:

•Men
•Women

By End User:

•Ambulatory Patients
•Post-operative Patients
•Pregnant Women
•Others

By Region:

•North America
•Latin America
•Europe
•East Asia
•South Asia
•Oceania
•Middle East and Africa (MEA)

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Anti-Embolism Stockings Market Snapshot 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Industry Developments and Key Market Events
1.5. Demand Side and Supply Side Analysis
1.6. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definitions
2.2. Value Chain Analysis
2.3. Macro-Economic Factors
2.3.1. Global GDP Outlook
2.3.2. Global Construction Industry Overview
2.3.3. Global Mining Industry Overview
2.4. Forecast Factors – Relevance and Impact
2.5. COVID-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter's Five Forces Analysis
2.8. Geopolitical Tensions: Market Impact
2.9. Regulatory and Technology Landscape
3. Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends
4. Price Trend Analysis, 2019-2032
4.1. Region-wise Price Analysis
4.2. Price by Segments
4.3. Price Impact Factors
5. Global Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
5.1. Key Highlights
5.2. Global Anti-Embolism Stockings Market Outlook: Product
5.2.1. Introduction/Key Findings
5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
5.2.3.1. Calf-length
5.2.3.2. Thigh-length
5.2.4. Market Attractiveness Analysis: Product
5.3. Global Anti-Embolism Stockings Market Outlook: Demography
5.3.1. Introduction/Key Findings
5.3.2. Historical Market Size (US$ Mn) Analysis by Demography, 2019-2024
5.3.3. Current Market Size (US$ Mn) Forecast, by Demography, 2025-2032
5.3.3.1. Men
5.3.3.2. Women
5.3.4. Market Attractiveness Analysis: Demography
5.4. Global Anti-Embolism Stockings Market Outlook: End User
5.4.1. Introduction/Key Findings
5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
5.4.3.1. Ambulatory Patients
5.4.3.2. Post-operative Patients
5.4.3.3. Pregnant Women
5.4.4. Market Attractiveness Analysis: End User
6. Global Anti-Embolism Stockings Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
7.4.1. Calf-length
7.4.2. Thigh-length
7.5. North America Market Size (US$ Mn) Forecast, by Demography, 2025-2032
7.5.1. Men
7.5.2. Women
7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
7.6.1. Ambulatory Patients
7.6.2. Post-operative Patients
7.6.3. Pregnant Women
8. Europe Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
8.3.1. Germany
8.3.2. Italy
8.3.3. France
8.3.4. U.K.
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
8.4.1. Calf-length
8.4.2. Thigh-length
8.5. Europe Market Size (US$ Mn) Forecast, by Demography, 2025-2032
8.5.1. Men
8.5.2. Women
8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
8.6.1. Ambulatory Patients
8.6.2. Post-operative Patients
8.6.3. Pregnant Women
9. East Asia Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
9.4.1. Calf-length
9.4.2. Thigh-length
9.5. East Asia Market Size (US$ Mn) Forecast, by Demography, 2025-2032
9.5.1. Men
9.5.2. Women
9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
9.6.1. Ambulatory Patients
9.6.2. Post-operative Patients
9.6.3. Pregnant Women
10. South Asia & Oceania Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of SAO
10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
10.4.1. Calf-length
10.4.2. Thigh-length
10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Demography, 2025-2032
10.5.1. Men
10.5.2. Women
10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
10.6.1. Ambulatory Patients
10.6.2. Post-operative Patients
10.6.3. Pregnant Women
11. Latin America Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of LATAM
11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
11.4.1. Calf-length
11.4.2. Thigh-length
11.5. Latin America Market Size (US$ Mn) Forecast, by Demography, 2025-2032
11.5.1. Men
11.5.2. Women
11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
11.6.1. Ambulatory Patients
11.6.2. Post-operative Patients
11.6.3. Pregnant Women
12. Middle East & Africa Anti-Embolism Stockings Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Northern Africa
12.3.4. Rest of MEA
12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
12.4.1. Calf-length
12.4.2. Thigh-length
12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Demography, 2025-2032
12.5.1. Men
12.5.2. Women
12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
12.6.1. Ambulatory Patients
12.6.2. Post-operative Patients
12.6.3. Pregnant Women
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping
13.2.2. Competition Dashboard
13.3. Company Profiles
13.3.1. MD
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio/Offerings
13.3.1.3. Key Financials
13.3.1.4. SWOT Analysis
13.3.1.5. Company Strategy and Key Developments
13.3.2. Medtronic(Covidien)
13.3.3. Sigvaris, Medi
13.3.4. BSN Medical
13.3.5. Juzo
13.3.6. 3M
13.3.7. Bauerfeind AG
13.3.8. Thuasne Corporate
13.3.9. Pretty Legs Hosiery
13.3.10. Salzmann-Group
13.3.11. Paul Hartmann
13.3.12. Cizeta Medicali
13.3.13. Belsana Medical
13.3.14. Gloria Med
13.3.15. Zhende Medical Group
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations